Analyst Ratings for Carbylan Therapeutics (CBYL)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/18/2016 | Citizens | N/A | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
0.64 (0.68) |
6.25% | Details |
| 2/2/2016 | Leerink | N/A | Downgrade | Market Perform (Outperform) |
1.80 (15.00) |
2.47 (0.68) |
-72.47% | Details |
 |
||||||||
|
||||||||
